Abstract:Hepatocyte nuclear factor 4 alpha antisense 1 ( HNF4A-AS1 ) is a long noncoding RNA (lncRNA) gene physically located next to the transcription factor HNF4A gene in the human genome. Its transcription products have been reported to inhibit the progression of hepatocellular carcinoma (HCC) and negatively regulate the expression of cytochrome P450s (CYPs), including CYP1A2, 2B6, 2C9, 2C19, 2E1, and 3A4. By altering CYP expression, lncRNA HNF4A-AS1 also contributes to the susceptibility of drug-induced liver injury. Thus, HNF4A-AS1 lncRNA is a promising target for controlling HCC and modulating drug metabolism. However, HNF4A-AS1 has four annotated alternative transcripts in the human genome browsers, and it is unclear which transcripts the small interfering RNAs or small hairpin RNAs used in the previous studies are silenced and which transcripts should be used as the target. In this study, four annotated and two newly identified transcripts were confirmed. These six transcripts showed different expression levels in different liver disease conditions, including metabolic dysfunction-associated steatotic liver disease, alcohol-associated liver disease, and obesity. The expression patterns of all HNF4A-AS1 transcripts were further investigated in liver cell growth from human embryonic stem cells to matured hepatocyte-like cells, HepaRG differentiation, and exposure to rifampicin treatment. Several HNF4A-AS1 transcripts highly displayed correlations with these situations. In addition, some of the HNF4A-AS1 transcripts also showed a strong correlation with CYP3A4 during HepaRG maturation and rifampicin exposure. Our findings provide valuable insights into the specific roles of HNF4A-AS1 transcripts, paving the way for more targeted therapeutic strategies for liver diseases and drug metabolism. SIGNIFICANCE STATEMENT This study explores the alternative transcripts of HNF4A-AS1, showing how their expression changes in different biological conditions, from various liver diseases to the growth and differentiation of hepatocytes and drug metabolism. The generated knowledge is essential for understanding the independent roles of different transcripts from the same lncRNA in different liver diseases and drug metabolism situations.

A Long Non-Coding Rna, Apoa4-As, Regulates Apoa4 Expression Depending On Hur In Mice

Aberrant Hepatic Microrna Expression in Nonalcoholic Fatty Liver Disease

Long Non-Coding Rna Profiling In A Non-Alcoholic Fatty Liver Disease Rodent Model: New Insight Into Pathogenesis

Identification of Novel Antisense Long Non-Coding RNA APMAP-AS That Modulates Porcine Adipogenic Differentiation and Inflammatory Responses

Correlations of Long Noncoding RNA HNF4A-AS1 Alternative Transcripts with Liver Diseases and Drug Metabolism

Systematic analysis of long non-coding RNA and mRNA expression changes in ApoE-deficient mice during atherosclerosis.

Long non-coding RNAs regulate fatty acid and cholesterol metabolism

The Long Noncoding RNA HNF1A-AS1 with Dual Functions in the Regulation of Cytochrome P450 3A4.

A novel lncRNA GM47544 modulates triglyceride metabolism by inducing ubiquitination-dependent protein degradation of APOC3

LncNONMMUG027912 alleviates lipid accumulation through AMPKα/mTOR/SREBP1C axis in nonalcoholic fatty liver

The Long Noncoding RNA ASNR Regulates Degradation of Bcl-2 Mrna Through Its Interaction with AUF1

Single-cell RNA sequencing reveals a novel inhibitory effect of ApoA4 on NAFL mediated by liver-specific subsets of myeloid cells

A New lncRNA, lnc-LLMA, Regulates Lipid Metabolism in Pig Hepatocytes

LncRNA-AK012226 is Involved in Fat Accumulation in Db/db Mice Fatty Liver and Non-alcoholic Fatty Liver Disease Cell Model

Long Non-Coding Rna Hulc Protects Against Atherosclerosis Via Inhibition Of Pi3k/Akt Signaling Pathway

Lnc027912 Reduces Lipid Accumulation Through Akt/MTOR/SREBP1C Axis in Hepatic Cells

Profile Analysis and Functional Modeling Identify Circular RNAs in Nonalcoholic Fatty Liver Disease As Regulators of Hepatic Lipid Metabolism

1822-P: Regulation of Trafficking of Lipids from Liver to Fat by ApoA4 in a Mouse Model of Nonalcoholic Steatohepatitis

Adiponectin AS Lncrna Inhibits Adipogenesis by Transferring from Nucleus to Cytoplasm and Attenuating Adiponectin Mrna Translation.

Identification Of A Novel Human Long Non-Coding Rna That Regulates Hepatic Lipid Metabolism By Inhibiting Srebp-1c

Overexpressed lncRNA ROR Promotes the Biological Characteristics of ox-LDL-Induced HUVECs via the let-7b-5p/HOXA1 Axis in Atherosclerosis